Synergo for Bladder Cancer

Startpagina
Nederland
Amstelveen
Synergo for Bladder Cancer

Synergo® is an advanced technology for the treatment of non-muscle invasive bladder cancer: local microwave (RF) induced hyperthermia with chemotherapy

19/11/2025

Thrilled to see this new real-world evidence using RITE + intravesical MMC in NMIBC.
A heartfelt thank you to Prof. Shahrokh F. Shariat, Assoc. Prof. (Priv.-Doz.) Dr. David D’Andrea, Dr. Elisabeth Grobet-Jeandin, and the rest of the team for their important work with the device.
As the authors conclude:
“RITE resulted in notable antitumor activity and allows for the avoidance of more aggressive and quality-of-life-limiting therapies, such as radical cystectomy.”
Highlights at 24 months in a challenging patient group (including BCG failures, those ineligible for BCG or cystectomy): high-grade recurrence-free survival of ~74.8% and cystectomy-free survival of 93.8%.
Thank you for advancing bladder-sparing options and giving more patients hope for less invasive, quality-of-life-preserving care. 🙏
S. Mero, K. Oberneder, J. Weiss, E. Grobet-Jeandin, A. Grégoris, P. Sèbe, S. Shariat, D. D’Andrea,
Hipertermia inducida por radiofrecuencia en el cáncer de vejiga no músculo invasor: resultados oncológicos en un escenario real,Actas Urológicas Españolas, Volume 49, Issue 5, 2025, 501746,
ISSN 0210-4806
;

10/09/2025

For patients with recurrent or high-risk NMIBC, the treatment journey is often marked by uncertainty.
Synergo therapy is designed to deliver:
✅ A minimally invasive, outpatient procedure
✅ Preservation of the bladder
✅ Improved quality of life through fewer recurrences
Every patient should have access to treatments that address the cancer while also supporting quality of life after diagnosis.

08/09/2025

Standard intravesical chemotherapy faces well-known challenges: recurrence and progression rates remain high.
Synergo therapy integrates intravesical chemotherapy with radiofrequency-induced hyperthermia.
Clinical studies demonstrate:
🟡 Reduced recurrence rates
🟡 Longer disease-free intervals
🟡 A bladder-sparing approach for high-risk NMIBC patients
Learn how Synergo therapy is reshaping the future of bladder cancer treatment.

Adres

147A Amsterdamseweg
Amstelveen
1182GT

Telefoon

+31(0)206423719

Website

http://www.synergo-medical.com/

Meldingen

Wees de eerste die het weet en laat ons u een e-mail sturen wanneer Synergo for Bladder Cancer nieuws en promoties plaatst. Uw e-mailadres wordt niet voor andere doeleinden gebruikt en u kunt zich op elk gewenst moment afmelden.

Contact De Praktijk

Stuur een bericht naar Synergo for Bladder Cancer:

Snelkoppelingen

Wilt u dat uw praktijk hét hoogst genoteerde Kliniek in Amstelveen wordt?

SYNERGO RADIOFREQUENCY - INDUCED THERMOCHEMOTHERAPY FOR THE TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER

Medical Enterprises Group is a dynamic medical device company. It has its headquarters in Amsterdam, The Netherlands, where sales and marketing activities are managed. Research and Development, technical support and clinical activities are managed from the facility in Israel. The company is focused on developing minimally invasive therapeutic technologies which provide benefits for both patient and healthcare system.